Mike McCarron on Scotland’s Futures Forum and the systems approach

Can’t see the video?

You need to upgrade your Flash Player to version 8 or newer.
Click HERE to get it.

Mike McCarron
Mike McCarron
Location: Scotland
View Contributor Video List >>
VIDEO NUMBER:
121
CATEGORY:
Policy, Strategy And Research
DATE ADDED:
21-10-2008
DESCRIPTION
 Mike talks about the systems approach described in ‘Approaches to Alcohol and Drugs in Scotlnd: A Question of Architecture’

View related videos
Footnotes
1) Report: Approaches to Alcohol and Drugs in Scotland – ‘A Question of Architecture’ Scotland’s Futures Forum
News and articles library
National survey of hepatitis C services in prisons in England published >>

23rd July 12 – The first dedicated survey of hepatitis C services in prisons in England shows that diagnosis and treatment for chronic hepatitis C infection is available to prisoners in most prisons in England
Measuring Subjective Wellbeing in the UK, First Annual ONS Experimental Subjective Well-being Results >>

23rd July 12 –  Measuring Subjective Wellbeing in the UK, First Annual ONS Experimental Subjective Well-being Results: This article will present estimates of subjective well-being from the first annual experimental Annual Population Survey (APS) Subjective Well-being dataset for April 2011 to March 2012.
10 steps to an Aids-free generation >>

23rd July 12 – The UK has one of the lowest HIV rates for this group (2.5 per cent of HIV-positive people) because of harm-reduction programmes such as needle exchange. In countries with no or few such initiatives, such as Russia, nearly half of all people living with the virus contract it from injecting drugs.
Active injecting drug users must be provided with adherence support when they start HIV therapy >>

22nd June 12 –  It is well recognised that active injecting drug use is associated with poorer responses to HIV therapy. However, the impact of specific patterns of injecting on the chances of virological suppression is poorly understood.

Therefore, investigators from Vancouver designed a longitudinal study involving 267 people with a history of drug use who started HIV therapy for the first time between 1996 and 2008.

Related Videos